Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases - Yamashita, S; Masuda, D; Matsuzawa, Y (Current Atherosclerosis Report, 2020)